472 related articles for article (PubMed ID: 15969874)
1. Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale.
Cappelleri JC; Bushmakin AG; Baker CL; Merikle E; Olufade AO; Gilbert DG
Curr Med Res Opin; 2005 May; 21(5):749-60. PubMed ID: 15969874
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Chinese versions of the Minnesota nicotine withdrawal scale and the questionnaire on smoking urges-brief.
Yu X; Xiao D; Li B; Liu Y; Wang G; Chen J; Bai C; Pan J; Wan H; Li Q; Zhou X; Liao R; Li Q; Wang C; Chen R; Tang Y; Mo H; Zhao M; Du J; Li J; Kang L; Wang C
Nicotine Tob Res; 2010 Jun; 12(6):630-4. PubMed ID: 20498226
[TBL] [Abstract][Full Text] [Related]
3. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
4. A self-administered questionnaire to measure cigarette withdrawal symptoms: the Cigarette Withdrawal Scale.
Etter JF
Nicotine Tob Res; 2005 Feb; 7(1):47-57. PubMed ID: 15804677
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the psychometric properties of three cigarette withdrawal scales.
Etter JF; Hughes JR
Addiction; 2006 Mar; 101(3):362-72. PubMed ID: 16499509
[TBL] [Abstract][Full Text] [Related]
6. Effect of varenicline on individual nicotine withdrawal symptoms: a combined analysis of eight randomized, placebo-controlled trials.
Foulds J; Russ C; Yu CR; Zou KH; Galaznik A; Franzon M; Berg A; Hughes JR
Nicotine Tob Res; 2013 Nov; 15(11):1849-57. PubMed ID: 23694782
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
[TBL] [Abstract][Full Text] [Related]
8. Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.
Stapleton JA; Watson L; Spirling LI; Smith R; Milbrandt A; Ratcliffe M; Sutherland G
Addiction; 2008 Jan; 103(1):146-54. PubMed ID: 18028247
[TBL] [Abstract][Full Text] [Related]
9. Confirmatory factor analysis of the Minnesota Nicotine Withdrawal Scale.
Toll BA; O'Malley SS; McKee SA; Salovey P; Krishnan-Sarin S
Psychol Addict Behav; 2007 Jun; 21(2):216-25. PubMed ID: 17563141
[TBL] [Abstract][Full Text] [Related]
10. Factor Analysis and Psychometric Properties of the Minnesota Nicotine Withdrawal Scale and the Minnesota Nicotine Withdrawal Scale-Revised: Italian Version.
Svicher A; Beghè A; Mangiaracina G; Cosci F
Eur Addict Res; 2017; 23(3):157-162. PubMed ID: 28641297
[TBL] [Abstract][Full Text] [Related]
11. Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials.
Shiffman S; West R; Gilbert D;
Nicotine Tob Res; 2004 Aug; 6(4):599-614. PubMed ID: 15370156
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the content-, construct- and predictive validity of the cigarette dependence scale and the Fagerström test for nicotine dependence.
Etter JF
Drug Alcohol Depend; 2005 Mar; 77(3):259-68. PubMed ID: 15734226
[TBL] [Abstract][Full Text] [Related]
13. The nicotine dependence syndrome scale: a multidimensional measure of nicotine dependence.
Shiffman S; Waters A; Hickcox M
Nicotine Tob Res; 2004 Apr; 6(2):327-48. PubMed ID: 15203807
[TBL] [Abstract][Full Text] [Related]
14. Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire.
Cappelleri JC; Bushmakin AG; Baker CL; Merikle E; Olufade AO; Gilbert DG
Addict Behav; 2007 May; 32(5):912-23. PubMed ID: 16875787
[TBL] [Abstract][Full Text] [Related]
15. Assessing DSM-IV nicotine withdrawal symptoms: a comparison and evaluation of five different scales.
West R; Ussher M; Evans M; Rashid M
Psychopharmacology (Berl); 2006 Mar; 184(3-4):619-27. PubMed ID: 16308727
[TBL] [Abstract][Full Text] [Related]
16. Social anxiety and fear of negative evaluation: construct validity of the BFNE-II.
Carleton RN; Collimore KC; Asmundson GJ
J Anxiety Disord; 2007; 21(1):131-41. PubMed ID: 16675196
[TBL] [Abstract][Full Text] [Related]
17. [Validation of the French translation and factorial structure of the Tiffany and Drobes Smoking Urge Questionnaire].
Guillin O; Krebs MO; Bourdel MC; Olie JP; Loo H; Poirier MF
Encephale; 2000; 26(6):27-31. PubMed ID: 11217535
[TBL] [Abstract][Full Text] [Related]
18. The cognitive risk profile for pain: development of a self-report inventory for identifying beliefs and attitudes that interfere with pain management.
Cook AJ; Degood DE
Clin J Pain; 2006 May; 22(4):332-45. PubMed ID: 16691085
[TBL] [Abstract][Full Text] [Related]
19. Nicotine dependence, depression, and gender: characterizing phenotypes based on withdrawal discomfort, response to smoking, and ability to abstain.
Pomerleau OF; Pomerleau CS; Mehringer AM; Snedecor SM; Ninowski R; Sen A
Nicotine Tob Res; 2005 Feb; 7(1):91-102. PubMed ID: 15804681
[TBL] [Abstract][Full Text] [Related]
20. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
